Credit Suisse’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $49.6K | Sell |
18,517
-755
| -4% | -$1.83K | ﹤0.01% | 2943 |
|
|
2023
Q4 | $57.6K | Buy |
19,272
+1,544
| +9% | +$2K | ﹤0.01% | 3042 |
|
|
2023
Q3 | $17.4K | Sell |
17,728
-2,579
| -13% | -$3.73K | ﹤0.01% | 3127 |
|
|
2023
Q2 | $28.2K | Sell |
20,307
-46,292
| -70% | -$64.6K | ﹤0.01% | 3150 |
|
|
2023
Q1 | $106K | Buy |
66,599
+4,667
| +8% | +$24.1K | ﹤0.01% | 3200 |
|
|
2022
Q4 | $386K | Buy |
61,932
+45,809
| +284% | +$328K | ﹤0.01% | 2926 |
|
|
2022
Q3 | $108K | Sell |
16,123
-31,666
| -66% | -$217K | ﹤0.01% | 3418 |
|
|
2022
Q2 | $304K | Buy |
47,789
+29,094
| +156% | +$165K | ﹤0.01% | 3156 |
|
|
2022
Q1 | $86K | Sell |
18,695
-184,072
| -91% | -$790K | ﹤0.01% | 3487 |
|
|
2021
Q4 | $1.01M | Sell |
202,767
-56,301
| -22% | -$451K | ﹤0.01% | 3300 |
|
|
2021
Q3 | $3.12M | Buy |
259,068
+159,308
| +160% | +$2.32M | ﹤0.01% | 2455 |
|
|
2021
Q2 | $2.11M | Sell |
99,760
-16,373
| -14% | -$394K | ﹤0.01% | 2829 |
|
|
2021
Q1 | $3.26M | Buy |
116,133
+33,682
| +41% | +$994K | ﹤0.01% | 2450 |
|
|
2020
Q4 | $2.14M | Sell |
82,451
-912,963
| -92% | -$27.3M | ﹤0.01% | 2769 |
|
|
2020
Q3 | $37M | Buy |
995,414
+139,576
| +16% | +$5.53M | 0.02% | 736 |
|
|
2020
Q2 | $43.9M | Sell |
855,838
-35,868
| -4% | -$1.5M | 0.03% | 585 |
|
|
2020
Q1 | $28.1M | Buy |
891,706
+3,965
| +0.4% | +$209K | 0.02% | 664 |
|
|
2019
Q4 | $52.9M | Sell |
887,741
-64,915
| -7% | -$2.92M | 0.04% | 518 |
|
|
2019
Q3 | $34.9M | Sell |
952,656
-108,684
| -10% | -$4.31M | 0.03% | 621 |
|
|
2019
Q2 | $49.4M | Sell |
1,061,340
-88,075
| -8% | -$4.14M | 0.04% | 453 |
|
|
2019
Q1 | $46.1M | Buy |
1,149,415
+177,780
| +18% | +$7.98M | 0.04% | 453 |
|
|
2018
Q4 | $44.7M | Buy |
971,635
+1,089
| +0.1% | +$52.5K | 0.05% | 422 |
|
|
2018
Q3 | $43.1M | Sell |
970,546
-123,053
| -11% | -$5.65M | 0.04% | 477 |
|
|
2018
Q2 | $42.9M | Buy |
1,093,599
+8,779
| +0.8% | +$444K | 0.04% | 445 |
|
|
2018
Q1 | $78.5M | Buy |
1,084,820
+68,714
| +7% | +$5.05M | 0.07% | 277 |
|
|
2017
Q4 | $66.9M | Sell |
1,016,106
-47,932
| -5% | -$2.58M | 0.06% | 331 |
|
|
2017
Q3 | $53.3M | Sell |
1,064,038
-49,757
| -4% | -$2.4M | 0.05% | 402 |
|
|
2017
Q2 | $51.5M | Buy |
1,113,795
+234,971
| +27% | +$8.64M | 0.05% | 398 |
|
|
2017
Q1 | $31M | Buy |
878,824
+183,440
| +26% | +$4.2M | 0.03% | 616 |
|
|
2016
Q4 | $8.71M | Buy |
695,384
+305,631
| +78% | +$3.64M | 0.01% | 1286 |
|
|
2016
Q3 | $5.4M | Buy |
389,753
+92,729
| +31% | +$1.05M | 0.01% | 1603 |
|
|
2016
Q2 | $2.94M | Buy |
297,024
+231,502
| +353% | +$3.84M | ﹤0.01% | 2043 |
|
|
2016
Q1 | $1.11M | Sell |
65,522
-15,052
| -19% | -$242K | ﹤0.01% | 2646 |
|
|
2015
Q4 | $1.79M | Buy |
80,574
+31,023
| +63% | +$783K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $1.17M | Sell |
49,551
-20,335
| -29% | -$1.28M | ﹤0.01% | 2691 |
|
|
2015
Q2 | $5.71M | Buy |
69,886
+26,273
| +60% | +$2.57M | 0.01% | 1626 |
|
|
2015
Q1 | $4.04M | Buy |
43,613
+23,983
| +122% | +$1.55M | ﹤0.01% | 1833 |
|
|
2014
Q4 | $794K | Buy |
+19,630
| New | +$601K | ﹤0.01% | 3342 |
|
Other funds holding ESPR
O
BG
WA
GPP
WP
TSC